By Tamara Mathias (Reuters) - Johnson & Johnson said on Wednesday that Fortive Corp had offered to buy its medical sterilization unit for about $2.7 billion in cash. J&J has been reviewing its portfolio of businesses and had recently said it was nearing a sale of its diabetes device unit for $2.1 billion. At the same time, the company has been building its drug pipeline and last year acquired Swiss biotech company Actelion in a $30 billion deal
from Latest News Business on Firstpost https://ift.tt/2xQbL6t
0 comments:
Post a Comment